BrainChip (BRN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Advanced customer engagements for commercialization and strengthened leadership team during the quarter.
Signed €190,000 in agreements with Frontgrade Gaisler and Airbus Defence and Space for Akida 1.0 in space applications.
Appointed Steven Brightfield as CMO and Dr. Jonathon Tapson as VP of Engineering; co-founder Anil Mankar to retire end of 2024.
Reconstituted Scientific Advisory Board with key industry leaders to guide R&D and strategy.
Financial highlights
Cash balance at 30 September 2024 was US$25.6M, up from US$10.9M in the prior quarter.
Net operating cash outflows were US$3.4M, slightly improved from US$3.9M in the previous quarter.
Cash inflow from customers was US$0.04M, similar to the prior quarter.
Total payments to suppliers and employees were US$4.0M, consistent with the previous quarter.
Recognized US$0.89M in unrealized FX gains from AUD cash revaluation post capital raising.
Outlook and guidance
Optimistic about future sales due to active customer engagements and interest, despite long sales cycles.
Proceeds from recent capital raising to support commercialization of Akida 2.0 and development of TENNs products.
Latest events from BrainChip
- Revenue up 374%, net loss reduced, and $37M raised to accelerate neuromorphic AI growth.BRN
H2 202526 Feb 2026 - Revenue up 72% and net loss reduced, with strong capital raises and key commercial wins.BRN
H2 202420 Feb 2026 - Cash position strengthened and new partnerships drive momentum for neuromorphic AI products.BRN
Q4 202529 Jan 2026 - Cash balance rose to $13.9M as AKD1500 enters volume production, backed by new capital and partnerships.BRN
Q3 20251 Dec 2025 - A pivotal year with a new product roadmap, higher bookings targets, and focus on shareholder alignment.BRN
AGM 202520 Nov 2025 - $35M placement and $2M SPP to accelerate edge AI commercialization and product expansion.BRN
Investor Presentation10 Nov 2025 - Edge AI and neuromorphic solutions drive growth across defense, healthcare, and consumer markets.BRN
Investor Presentation19 Oct 2025 - Revenue soared 859% and net loss narrowed, with new funding and partnerships fueling growth.BRN
H1 202521 Aug 2025 - Customer receipts surged and cash burn improved, supporting ongoing growth and innovation.BRN
Q2 202529 Jul 2025